Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol.
Interferon beta-1b-induced Sweet's syndrome in a patient with multiple sclerosis.
Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound.
Rapid exacerbation of neuromyelitis optica after rituximab treatment.
Monoclonal antibodies in MS: mechanisms of action.
Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis.
The Role of Endogenous IFN-β in the Regulation of Th17 Responses in Patients with Relapsing-Remitting Multiple Sclerosis.
Treatment satisfaction in multiple sclerosis.
Prediction of oxygen uptake during walking in ambulatory persons with multiple sclerosis.
Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
Functional Characterization of DNA Methylation in the Oligodendrocyte Lineage.
Dimethyl fumarate (BG-12, Tecfidera) - NICE gives initial "no" decision
Anti-JCV antibody levels in serum or plasma further define risk of natalizumab-associated PML.
Correction: Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Nephrotic-range proteinuria on interferon-β treatment: immune-induced glomerulonephritis or other pathway?
Estrogen treatment in multiple sclerosis.
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination.
Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS.
Drugs@FDA (Enter "glatiramer acetate" in search box.)
The challenge of comorbidity in clinical trials for multiple sclerosis.
Newly onset sinus bradycardia in the context of multiple sclerosis relapse.
Semen quality of 4480 young cancer and systemic disease patients: baseline data and clinical considerations.
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Identical lesion morphology in primary progressive and relapsing-remitting MS -an ultrahigh field MRI study.
Pages
« first
‹ previous
…
91
92
93
94
95
96
97
98
99
…
next ›
last »